|

HX008 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Taizhou Hanzhong biomedical co. LTD1
  • Jiyan Liu1

Indications

  • Cancer2
  • Penile Cancer1
  • Metastatic Colorectal Cancer1

Other2 trials

A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
Phase 3
MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.